Joe Keegan

Joe Keegan is a seasoned executive with extensive experience in the life sciences industry, particularly known for his role as CEO of ForteBio.12 During his tenure at ForteBio from 2007 to 2012, Keegan led the company through significant growth and financial milestones.13

Career Highlights

ForteBio Leadership:: As CEO, Keegan guided ForteBio through a Series C financing round and oversaw a period of rapid sales growth, increasing revenue from less than $5 million to $27 million.1 This successful growth culminated in the company's sale to Pall Corporation, which resulted in a $160 million return for investors.1

Previous Experience:: Before his role at ForteBio, Keegan served as CEO of Molecular Devices Corporation, a NASDAQ-listed company. There, he grew revenues from $25 million to $185 million and managed the company's acquisition by MDS Corporation for $615 million.1

Board Positions and Industry Involvement

Keegan has held several notable positions in the industry:

• Board member of Bio-Techne Corporation (NASDAQ)1
• Board member for various early- and growth-stage companies in life science tools and diagnostics1
• Former Chairman of the Analytical, Life Science & Diagnostics Association (ALDA)1
• Former Non-Executive Chairman of Labcyte Inc1
• Former Non-Executive Director of ProteinSimple Inc1

Education and Expertise

With over 30 years of experience in life science businesses, Keegan has established himself as a respected figure in the industry.3 His LinkedIn profile indicates connections to Boston University and Stanford University, suggesting these may be part of his educational background.4

Joe Keegan's LinkedIn username is indeed joe-keegan-8116719, as mentioned in the query.2